Sanofi SA (SNY)
45.41
-0.70
(-1.52%)
USD |
NASDAQ |
Apr 18, 16:00
45.40
-0.01
(-0.02%)
After-Hours: 20:00
Sanofi Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | 340.86M |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 236.22M |
| March 31, 2021 | |
| June 30, 2020 | 355.73M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -55.05M |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 848.95M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 1.762B |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 1.567B |
| March 31, 2016 | |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | |
| June 30, 2015 | 863.06M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 1.059B |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 194.62M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 487.93M |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | 121.03M |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | 322.05M |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-55.05M
Minimum
Jun 2019
355.73M
Maximum
Jun 2020
219.44M
Average
288.54M
Median
Stock Buybacks (Quarterly) Benchmarks
| AstraZeneca PLC | -21.00M |
| GSK PLC | -1.047M |
| Novo Nordisk A/S | 1.400B |
| Regeneron Pharmaceuticals Inc | 446.10M |
| Inhibrx Inc | -- |